{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:53:31Z","timestamp":1765806811400},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10147-008-0824-9","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T13:21:21Z","timestamp":1247232081000},"page":"249-253","source":"Crossref","is-referenced-by-count":5,"title":["Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Yuko","family":"Kijima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiji","family":"Yoshinaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munetsugu","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Umekita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumika","family":"Matsukita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hizuru","family":"Kumemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawara","family":"Funasako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Natsugoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,11]]},"reference":[{"key":"824_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","volume":"14","author":"J.R. Weiss","year":"2005","unstructured":"Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Bilmarkers Prev 14:20\u201326","journal-title":"Cancer Epidemiol Bilmarkers Prev"},{"key":"824_CR2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2005.10.035","volume":"23","author":"S.A. Narod","year":"2005","unstructured":"Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656\u20131663","journal-title":"J Clin Oncol"},{"key":"824_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14656566.8.2.193","volume":"8","author":"B.F. Cutuli","year":"2007","unstructured":"Cutuli BF (2007) Strategies in treating male breast cancer. Expert Opin Pharmacother 8:193\u2013202","journal-title":"Expert Opin Pharmacother"},{"key":"824_CR4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/dji240","volume":"97","author":"A.J. Swedlow","year":"2005","unstructured":"Swedlow AJ, Shoemaker MJ, Higgins CD, et al. (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204\u20131210","journal-title":"J Natl Cancer Inst"},{"key":"824_CR5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1742-1241.2002.tb11371.x","volume":"56","author":"M.D. Tischkowitz","year":"2002","unstructured":"Tischkowitz MD, Hodgson SV, Fentiman IS (2002) Male breast cancer: etiology, genetics and clinical management. Int J Clin Pract 56:750\u2013754","journal-title":"Int J Clin Pract"},{"key":"824_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008469-200208000-00001","volume":"11","author":"F. Levi","year":"2002","unstructured":"Levi F, Lucchini F, Vecchia CL (2002) Epidemiology of male breast cancer. Eur J Cancer Prev 11:315\u2013318","journal-title":"Eur J Cancer Prev"},{"key":"824_CR7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","volume":"137","author":"S.H. Giordano","year":"2002","unstructured":"Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Int Med 137:678\u2013687","journal-title":"Ann Int Med"},{"key":"824_CR8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/bjc.1963.75","volume":"17","author":"M.M. El-Gazayerli","year":"1963","unstructured":"El-Gazayerli MM, Abdel-Aziz AS (1963) On bilateral and male breast cancer in Egypt: a preliminary report and review of literature. Br J Cancer 17:566\u2013571","journal-title":"Br J Cancer"},{"key":"824_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jnci\/80.9.679","volume":"80","author":"H. Olsson","year":"1988","unstructured":"Olsson H, Ranstam J (1988) Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 80:679\u2013683","journal-title":"J Natl Cancer Inst"},{"key":"824_CR10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/02841869609084012","volume":"35","author":"P. Karamanakos","year":"1996","unstructured":"Karamanakos P, Apostolopoulos V, Fafauliotis S, et al. (1996) Synchronous bilateral primary male breast carcinoma with hyperprolactinoma. Acta Oncol 35:757\u2013759.","journal-title":"Acta Oncol"},{"key":"824_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1096-9098(199701)64:1<74::AID-JSO14>3.0.CO;2-W","volume":"64","author":"M.D. Volm","year":"1997","unstructured":"Volm MD, Talamanti MS, Thangavelu M, et al. (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64:74\u201378","journal-title":"J Surg Oncol"},{"key":"824_CR12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2741\/1891","volume":"11","author":"A.W. Hsing","year":"2006","unstructured":"Hsing AW, Chakkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388\u20131413","journal-title":"Front Biosci"},{"key":"824_CR13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","volume":"367","author":"I.S. Fetiman","year":"2006","unstructured":"Fetiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595\u2013604","journal-title":"Lancet"},{"key":"824_CR14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/(SICI)1097-0215(20000615)86:6<883::AID-IJC20>3.0.CO;2-F","volume":"86","author":"A. Valeri","year":"2000","unstructured":"Valeri A, Fournier G, Morin B, et al. (2000) Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 86:883\u2013887","journal-title":"Int J Cancer"},{"key":"824_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0594-103","volume":"7","author":"M.R. Stratton","year":"1994","unstructured":"Stratton MR, Ford D, Neuhausen S, et al. (1994) Familial breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7:103\u2013107","journal-title":"Nat Genet"},{"key":"824_CR16","first-page":"711","volume":"52","author":"A. Aarason","year":"1993","unstructured":"Aarason A, Barkardottir RB, Egilsson V (1993) Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 52:711\u2013719","journal-title":"Am J Hum Genet"},{"key":"824_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1677\/erc.0.0060131","volume":"6","author":"E. Simpson","year":"1999","unstructured":"Simpson E, Rubin G, Clyne C, et al. (1999) Local estrogen biosynthesis in males and females. Endocr Relat Cancer 6:131\u2013137","journal-title":"Endocr Relat Cancer"},{"key":"824_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0250001","volume":"25","author":"F. Labrie","year":"2000","unstructured":"Labrie F, Luu-The V, Lin SX, et al. (2000) Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and diseases. J Mol Endocrinol 25:1\u201316","journal-title":"J Mol Endocrinol"},{"key":"824_CR19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003088-199834050-00005","volume":"34","author":"C. Mahler","year":"1998","unstructured":"Mahler C, Berhelst J, Denis L (1998) Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer. Clin Pharmacokinet 34:405\u2013417","journal-title":"Clin Pharmacokinet"},{"key":"824_CR20","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2001.19.17.3750","volume":"19","author":"A.L. Potosky","year":"2001","unstructured":"Potosky AL, Knopf K, Clegg LX, et al. (2001) Quality-of-life outcomes after primary androgen deprivation therapy: results from the prostate cancer outcomes study. J Clin Oncol 19:3750\u20133757","journal-title":"J Clin Oncol"},{"key":"824_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-4295(01)01237-7","volume":"58","author":"G.J. Kolvenbag","year":"2001","unstructured":"Kolvenbag GJ, Iversen P, Newling DW (2001) Antiandgrogen monotherapy: a new form of treatment for patients with prostate cancer. Urology 58:16\u201323","journal-title":"Urology"},{"key":"824_CR22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/bjc.1980.313","volume":"42","author":"L.H. Sobin","year":"1980","unstructured":"Sobin LH, Sherif M (1980) Relation between male breast cancer and prostate cancer. Br J Cancer 42:787\u2013790","journal-title":"Br J Cancer"},{"key":"824_CR23","first-page":"1","volume":"58","author":"B.S. Schoenenberg","year":"1977","unstructured":"Schoenenberg BS (1977) Multiple primary malignancies. The Connecticut experience, 1935\u20131964. Recent results Cancer Res 58:1\u2013173","journal-title":"Recent results Cancer Res"},{"key":"824_CR24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.juro.2006.03.036","volume":"176","author":"C. Tellenberg","year":"2006","unstructured":"Tellenberg C, Malmer B, Wiklund F, Gronberg H (2006) Breast cancer as a second primary in patients with prostate cancer \u2014 estrogen treatment or association with family history of cancer? J Urol 176:538\u2013543","journal-title":"J Urol"},{"key":"824_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.5597.83","volume":"2","author":"W. Symmers","year":"1968","unstructured":"Symmers W (1968) Carcinoma of breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. BMJ 2:83\u201385","journal-title":"BMJ"},{"key":"824_CR26","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/jama.1988.03720150054036","volume":"259","author":"T.J. Pritchard","year":"1988","unstructured":"Pritchard TJ, Pankowsky DA, Crowe JP, et al. (1988) Breast cancer in a male to female transsexual. JAMA 259:2278\u20132280","journal-title":"JAMA"},{"key":"824_CR27","first-page":"353","volume":"145","author":"W.E. Bounds","year":"1993","unstructured":"Bounds WE, Burton GV, Schwalke MA (1993) Male breast cancer. J La State Med Soc 145:353\u2013356","journal-title":"J La State Med Soc"},{"key":"824_CR28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.SMJ.0000050686.54786.79","volume":"97","author":"K. Coard","year":"2004","unstructured":"Coard K, McCartney T (2004) Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence? Southern Med J 97:308\u2013310","journal-title":"Southern Med J"},{"key":"824_CR29","first-page":"300","volume":"25","author":"R.R. Howard","year":"1949","unstructured":"Howard RR, Grosjean WA, Kan W (1949) Bilateral mammary carcinoma in the male coincident with prolonged stilbestrol therapy. Surgery 25:300\u2013303","journal-title":"Surgery"},{"key":"824_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jama.1951.03670010011002","volume":"146","author":"J.A. McClure","year":"1951","unstructured":"McClure JA, Higgins CC (1951) Bilateral carcinoma of male breast after estrogen therapy. JAMA 146:7\u20139","journal-title":"JAMA"},{"key":"824_CR31","first-page":"698","volume":"92","author":"A. Emoto","year":"2001","unstructured":"Emoto A, Nasu N, Mimata H, et al. (2001) A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer (in Japanese). Nippon Hinyokika Gakkai Zasshi 92:698\u2013701","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"824_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10549-005-9107-6","volume":"97","author":"R.F. Staerkle","year":"2006","unstructured":"Staerkle RF, Lenzlinger PM, Suter SL, et al. (2006) Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. Breast Cancer Res Treat 97:173\u2013176","journal-title":"Breast Cancer Res Treat"},{"key":"824_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/dc.2840010108","volume":"1","author":"R.L. Katz","year":"1985","unstructured":"Katz RL, Raval P, Brooks TE, Ordonez NG (1985) Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine-needle aspiration biopsy. Diagn Cytopathol 1:28\u201332","journal-title":"Diagn Cytopathol"},{"key":"824_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0009-9120(94)90015-9","volume":"27","author":"H. Yu","year":"1994","unstructured":"Yu H, Diamandis EP, Sutherland DJA (1994) Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27:75\u201379","journal-title":"Clin Biochem"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-008-0824-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0824-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T23:29:57Z","timestamp":1685057397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-008-0824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1007\/s10147-008-0824-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}